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The enzyme 6-phospho-3-hexulose isomerase (YckF) from Bacillus
subtilis has been prepared and crystallized in a form suitable for
X-ray crystallographic analysis. Crystals were grown by the hanging-
drop method at 291 K using polyethylene glycol 2000 monomethyl-
ether as precipitant. They diffract beyond 1.7 AÊ using an in-house
Cu K source and belong to either space group P6522 or P6122, with
unit-cell parameters a = b = 72.4, c = 241.2 AÊ , and have two molecules
of YckF in the asymmetric unit.
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1. Introduction
6-Phospho-3-hexulose isomerase (PHI) cata-
lyses the isomerization of d-arabino-3-hexu-
lose-6-phosphate to d-fructose-6-phosphate, as
illustrated in Fig. 1. PHI is a key enzyme in the
®xation of carbon, in the form of formalde-
hyde, by methylotrophic bacteria. This process
is part of the ribulose monophosphate (RuMP)
pathway, the key function of which is the
condensation of formaldehyde with ribulose-5-
phosphate by 3-hexulose-6-phosphate synthase
(HPS) to form d-arabino-3-hexulose-6-phos-
phate, which in turn is isomerized by PHI to
fructose-6-phosphate. The subsequent meta-
bolism of fructose-6-phosphate leads to the
regeneration of the pentose phosphate
acceptor and the net production of triose
phosphate (Strùm et al., 1974). Until recently, it
was believed that such enzyme systems were
restricted solely to methylotrophic organisms.
However, the recent explosion of information
arising from genome-sequencing projects has
led to the identi®cation of similar genes in non-
methylotrophs such as B. subtilis (Kunst et al.,
1997; Reizer et al., 1997; Yasueda et al., 1999).
Investigation at the gene-expression level
suggests that in this organism these gene
products play a speci®c role in detoxi®cation.
For example, when B. subtilis was cultured in
the presence of formaldehyde, the expression
of PHI (i.e. YckF) and HPS (i.e. YckG) was
induced. The observation that methanol,
formate and methylamine did not elicit a
similar response and the fact that induction of
YckF and YckG expression was dependent on
another gene, yckH, strongly suggest that these
three genes function as a speci®c detoxi®cation
system for formaldehyde in this organism
(Yasueda et al., 1999).
The yckF gene from B. subtilis consists of a
558 bp open reading frame (ORF) which
encodes a 19.96 kDa protein (Kunst et al.,
1997). YckF exhibits signi®cant homology (34
and 37%, respectively) with functional PHIs
from the obligate methylotrophic bacterium
Methylomonas aminofaciens 77a (Sakai et al.,
1999) and the facultative methylotrophic
bacterium Mycobacterium gastri MB19 (Mitsui
et al., 2000; Fig. 2). YckF also shares 22.8%
identity with the putative CP0226 gene of
Chlamydophila pneumoniae AR39 and three
putative genes from Haemophilus in¯uenzae,
HI0143 (18%), HI1678 (18.6%) and HI0754
(14.8%). Similarity (16.2%) also exists to a
fructose-6-phosphate aminotransferase gene,
glmS, from B. subtilis. Although PHI enzymes
have been puri®ed and characterized from a
range of organisms (Beardsmore et al., 1982;
Ferenci et al., 1974; Kato et al., 1977; Sakai et
al., 1999; Mitsui et al., 2000), little is known
about their catalytic mechanism. Metal-ion
dependency is a common feature amongst
previously characterized sugar isomerases,
with cobalt, magnesium and manganese
predominantly implicated (Watt, 1998).
However, the PHI from Methylococcus
capsulatus has been shown to be fully active in
the absence of cations and to be inhibited by
various divalent cations (Ferenci et al., 1974).
However, it is currently unknown whether
YckF is active in the absence of cations.
Despite the importance of PHI in terms of
carbon ®xation, detoxi®cation and its potential
in biotransformation applications, little is
known about its structure or function. In this
paper, we present the cloning and over-
expression of the yckF gene using an Escher-
ichia coli expression system, together with its
puri®cation, crystallization and preliminary
X-ray diffraction analysis.
2. Experimental
2.1. Cloning, expression and purification
PfuTurbo DNA polymerase (Stratagene)
and the oligonucleotide primers 50-CATAT-
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GAAAACGACTGAATACG-30 and 50-
GGATCCCTATTCAAGGTTTGCGTG-30
were used to amplify the yckF gene from
B. subtilis 168 (ATCC 23857) genomic DNA.
This fragment encoded the yckF gene
¯anked by NdeI and BamHI restriction sites.
The 567 bp fragment was cloned using the
A-tailing procedure for cloning blunt-ended
PCR fragments into pGEMT-Easy (Pro-
mega). The insert was subcloned into the
expression vector pET28a (Novogen) on an
NdeI/BamHI restriction fragment, gener-
ating the plasmid pBSISO1. The recombi-
nant plasmid was transformed into E. coli
strain BL21 (DE3), which had been made
competent by the method of Hanahan
(1983). The transformants were cultured on
LB agar supplemented with 50 mg mlÿ1
kanamycin at 310 K. Cultures for induction
were inoculated from a 5 ml 16 h culture and
grown in LB supplemented with 50 mg mlÿ1
kanamycin. Isopropyl-thio--d-galactoside
was added to a ®nal concentration of 1 mM
when the optical density at 600 nm had
reached 0.7, after which incubation was
continued for a further 16 h at a reduced
temperature of 295 K. The bacteria were
harvested by centrifugation, resuspended in
20 mM Na2HPO4 buffer pH 7.4 containing
0.5 M NaCl and 10 mM imidazole and soni-
cated on ice for a total of 1 min using a 10 s
on and 10 s off cycle. Cell debris was
removed by centrifugation at 30 000g for
30 min. The crude extract was loaded onto
a PD-10 column (Pharmacia Biotech)
containing a 2 ml bed volume of nickel-
charged Fast Flow Chelating Sepharose.
Puri®cation was achieved as described by
the manufacturer, except for the inclusion of
two additional washing steps with 100 mM
imidazole. The eluted protein was buffer
exchanged into 20 mM Na HEPES buffer
pH 7.4 using a Sephadex PD-10 G-25M
column (Pharmacia Biotech). The purity of
YckF was assessed by SDS±PAGE analysis.
The puri®ed protein was concentrated using
a 10 kDa molecular-weight cutoff centrifu-
gation membrane (Amicon).
2.2. PHI assay
To determine whether recombinant YckF
was active, it was assayed according to the
method of Arfman et al. (1990) with modi-
®cations as described by Yasueda et al.
(1999). This multi-enzyme linked assay
features ribose-5-phosphate conversion to
ribulose-5-phosphate by ribose phosphate
isomerase. The product of this ®rst reaction
is then combined with formaldehyde by
3-hexulose-6-phosphate synthase, gener-
ating d-arabino-3-hexulose-6-phosphate, the
substrate for YckF. The product of YckF,
fructose-6-phosphate, then undergoes iso-
merization by phosphoglucose isomerase,
yielding glucose-6-phosphate, which is
®nally converted to 6-phosphoglucono--
lactone by glucose-6-phosphate dehydro-
genase, leading to the production of
NADPH, which is followed at 340 nm.
2.3. Crystallization
Crystals of YckF were grown by vapour-
phase diffusion using the hanging-drop
method in Falcon 3047 multiwell plates at
291 K. The drops comprised an equal
volume, 1 or 2 ml, of YckF at a concentration
of 20 mg mlÿ1 mixed with reservoir solution.
Crystals of YckF appeared in numerous
conditions of the crystallization screen as
described by Brzozowski & Walton (2001)
after only a few hours. These initial condi-
tions were optimized by the addition of 10 or
20%(v/v) of either glycerol, 2-methyl-2,4-
pentandiol (MPD) or ethylene glycol and
reducing the protein concentration to
10 mg mlÿ1. When the reservoir solution
comprised 0.8 M sodium formate, 1 mM
EDTA, 25%(w/v) polyethylene glycol 2000
monomethylether and 10%(v/v) MPD in
20 mM Na HEPES buffer pH 7.4, hexagonal
crystals appeared after 24 h and had
approximate dimensions of 0.2  0.2 
0.1 mm (Fig. 3). This buffer solution was also
a cryoprotectant, enabling crystals to be
mounted directly into a rayon-®bre loop and
placed into a stream of N2 gas at 120 K.
2.4. Data collection and processing
Native X-ray diffraction data were
collected in the home laboratory from a
single crystal at 120 K using a 345 mm MAR
Research imaging-plate detector on a
Rigaku rotating-anode RU-200 X-ray
generator with a Cu target operating at
50 kV and 100 mA with the use of focusing
X-ray optics (MSC). 40.4 of data to a
resolution of 2.6 AÊ were collected with an
oscillation range of 0.2 and an exposure
time of 10 min per image. Data were
processed and reduced using the DENZO
and SCALEPACK programs (Otwinowski
& Minor, 1997).
3. Results and discussion
Puri®ed YckF was apparently pure as
judged by SDS±PAGE analysis and ran as a
single well de®ned band when conducting
non-denaturing polyacrylamide gel electro-
phoresis (data not shown). MALDI-TOF
mass-spectrometric analysis indicated that
recombinant YckF had a molecular mass of
22.16 kDa, consistent with the predicted
value, 22.13 kDa, which includes the N-
terminal polyhistidine tag. The puri®ed
protein was very stable and could be stored
at 277 K at a protein concentration of
20 mg mlÿ1 in 20 mM Na HEPES buffer pH
7.4. To determine whether YckF was active,
it was assayed, as described in x2.2, by
measuring the production of NADPH at
Figure 2
A ClustalW (1.8) multiple sequence alignment of 6-phospho-3-hexulose isomerases from B.
subtilis, Mycobacterium gastri and Methylmonas aminofaciens. The position of identical residues (asterisks)
and conserved (:) and semi-conserved (.) substitutions are indicated.
Figure 1
6-Phospho-3-hexulose isomerase catalyses the
isomerization of d-arabino-3-hexulose-6-phosphate
to d-fructose-6-phosphate.
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340 nm. Recombinant YckF had a speci®c
activity of 193 mmol of NADP+ reduced per
minute per milligram of pure enzyme.
Crystals of YckF belong to space group
P6522 or P6122, with unit-cell parameters
a = b = 72.4, c = 241.2 AÊ , and most likely
have two protein molecules in the asym-
metric unit. Crystals of YckF diffracted very
strongly in the home laboratory, but the
resolution of such data was constrained to
2.6 AÊ owing to the long c axis. 202 840
observations were merged to give 12 384
unique re¯ections, with an Rmerge
(
P
hkl
P
i jIhkl ÿ hIhklij/
P
hkl
P
i Ihkl) of 0.019,
a mean I/(I) of 48.9, a multiplicity of
observation of 4.2 and a completeness of
94% in the 12±2.6 AÊ resolution range. The
data were very strong, with an Rmerge of
0.027 and a mean I/(I) of 32.4 and a
multiplicity of observation of 4.4 in the outer
resolution shell (2.69±2.6 AÊ ). Assuming that
there are two molecules in the asymmetric
unit, the crystal packing density was deter-
mined to be 2.07 AÊ 3 Daÿ1, which corre-
sponds to a solvent content of 40.2%
(Matthews, 1968). Alternatively, though less
likely, one molecule in the asymmetric unit
corresponds to a density and solvent content
of 4.15 AÊ 3 Daÿ1 and 70.1%, respectively.
The structure of YckF will allow illumi-
nation of the catalytic mechanism and
substrate speci®city of this important family
of proteins and will give an insight into the
closely related homologues of unknown
function from various pathogenic bacteria
such as H. in¯uenzae and C. pneumoniae.
These putative enzymes, although distantly
related, appear to possess the same catalytic
machinery as YckF from B. subtilis. Struc-
tural data will also allow the rational design
of catalysts for speci®c biotransformations
using PHI with other RuMP pathway
enzymes. Selenomethionine-substituted pro-
tein is currently being produced to aid rapid
structure determination.
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Figure 3
A single crystal of YckF from B. subtilis. This
hexagonal crystal with dimensions 0.1  0.1 
0.2 mm was obtained using 20 mM Na HEPES buffer
pH 7.4 containing 0.8 M sodium formate, 1 mM
EDTA, 25%(w/v) polyethylene glycol 2000 mono-
methylether and 10%(v/v) MPD.
